+321 123 4567
info@test.com
My Account
  • Home
  • News
    • Publications
    • Videos
  • About
    • The ASCENT project
    • Digital Adherence Technologies
    • Our Approach
    • Our Team
    • Funding & support
    • Consortium Partners
  • Countries
    • Ethiopia
    • South Africa
    • Tanzania
    • The Philippines
    • Ukraine
  • Market
    • Market landscape
    • Market size
    • Market Growth
      • DAT use beyond TB
      • DAT user growth
      • Optimal DAT design
  • Products
    • Adherence Platforms
  • Resources
  • connect with us

ASCENT Ethiopia, Research Results Dissemination and Closeout Event

1 year ago
ASCENT, Ethiopia
163 Comments

Results from Ethiopia reflect the usability and acceptability of DATs by TB care providers and people with TB, indicating the potential for wider adoption of DATs to support the TB care cascade throughout the region.

Read More

Highlights and key messages from the ASCENT project at the Union

2 years ago
ASCENT, The Union Conference
39 Comments

The unveiling of the ASCENT study results at the Union 2023 in Paris marked a crucial turning point in the approach to TB treatment, and in the case of ASCENT, the potential future of DATs.

Read More

ASCENT: Five years of transformative impact to support tuberculosis treatment

2 years ago
ASCENT
40 Comments

With the idea of empowering people through Digital Adherence Technology (DAT), the ASCENT proeject has proven to be a game-changer in the realm of TB treatment and care. 

Read More

Preparing for The Union World Conference on Lung Health 2023

2 years ago
ASCENT, The Union Conference
43 Comments

After five years of dedication and tireless effort, the ASCENT Project team is gearing up for a significant milestone—the Union World Conference on Lung Health 2023, set to be held in Paris.

Read More

Technical brief: 5 Country Experiences with Digital Adherence Technologies

2 years ago
ASCENT
987 Comments

Based on our experiences with implementing digital adherence technologies (DAT) at scale in five different contexts, we wrote a technical brief to highlight and summarize the ASCENT project implementation.

Read More

ASCENT presents two out of ten top-scoring abstracts at the Union World Conference on Lung Health 2022

3 years ago
ASCENT
11 Comments

The ASCENT project is beyond exited to join the Union World Conference 2022 starting tomorrow, and presents several oral abstracts, symposia and e-posters.

Read More

ASCENT releases the ‘The Role of Digital Platforms in Medication Adherence’ to provide insight in platforms used for digital adherence technologies

3 years ago
ASCENT
21 Comments

This report, written by consortium partner PATH, captures the current state of the digital platform market.

Read More

Video: This is how Video Observed Treatment can help tuberculosis patients

3 years ago
ASCENT
7 Comments

Chidi Egwuatu from Nigeria wasn’t able to play football or sit in a vehicle for longer than 30 minutes before he started his tuberculosis treatment. He says: “The video helps me, it reminds me to take my medication on time”.

Read More

ASCENT pleased to see updated WHO guidance on tuberculosis care and support

3 years ago
ASCENT
9 Comments

The ASCENT project is pleased the WHO provided this guidance, since it has been our aim from the start to generate pragmatic evidence that DATs can empower TB-patients during their treatment.

Read More

ASCENT: invest in innovative digital tools to end TB

3 years ago
ASCENT
11 Comments

The Unitaid-funded ASCENT project has entered its final year and is well on its way in showing the benefits in helping people affected by TB with their treatment by using digital adherence technology such as smart pill boxes, medication sleeves and video supported treatment.

Read More

THE ASCENT PROJECT

The ASCENT project helps people affected with TB successfully complete their treatment through the use of digital adherence technologies and data-driven support interventions, utilizing smart pill boxes and other innovations.

Sign up to our newsletter

connect with us

Twitter
Facebook

This project is made possible thanks to
Unitaid funding and support.

Disclaimer – Privacy and Cookie statement